Optimizing treatment of diabetes and cardiovascular disease with combined α,β-blockade

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.8, 2005-08, pp. : 1191-1200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 949-955

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 10, 2015-10 ,pp. : 949-955

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of combined treatment with α/β-arteether and sulfadoxine–pyrimethamine, for cases of Plasmodium falciparum malaria in Jharkhand, India

By Singh R. K.

Annals of Tropical Medicine and Parasitology, Vol. 101, Iss. 3, 2007-04 ,pp. : 271-273

Maney Publishing

Access to resources Recommend Favorite

Diabetes and cardiovascular disease: time for individualized risk reduction

By McFarlane Samy I Sowers James R

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 451-453

Future Medicine

Access to resources Recommend Favorite

Aspirin in the Treatment and Prevention of Cardiovascular Disease

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2004-11 ,pp. : 1-13

Karger

Access to resources Recommend Favorite